• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者拒绝针对癌症的手术:一项全州范围的分析。

Prostate cancer patients' refusal of cancer-directed surgery: a statewide analysis.

作者信息

Islam K M, Wen Jiajun

机构信息

Department of Epidemiology, College of Public Health, University of Nebraska Medical Center, Omaha, NE 68198, USA.

出版信息

Prostate Cancer. 2015;2015:829439. doi: 10.1155/2015/829439. Epub 2015 Apr 20.

DOI:10.1155/2015/829439
PMID:25973276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4418003/
Abstract

Introduction. Prostate cancer is the most common cancer among men in USA. The surgical outcomes of prostate cancer remain inconsistent. Barriers such as socioeconomic factors may play a role in patients' decision of refusing recommended cancer-directed surgery. Methods. The Nebraska Cancer Registry data was used to calculate the proportion of prostate cancer patients recommended the cancer-directed surgery and the surgery refusal rate. Multivariate logistic regression was applied to analyze the socioeconomic indicators that were related to the refusal of surgery. Results. From 1995 to 2012, 14,876 prostate cancer patients were recommended to undergo the cancer-directed surgery in Nebraska, and 576 of them refused the surgery. The overall refusal rate of surgery was 3.9% over the 18 years. Patients with early-stage prostate cancer were more likely to refuse the surgery. Patients who were Black, single, or covered by Medicaid/Medicare had increased odds of refusing the surgery. Conclusion. Socioeconomic factors were related to the refusal of recommended surgical treatment for prostate cancer. Such barriers should be addressed to improve the utilization of surgical treatment and patients' well-being.

摘要

引言。前列腺癌是美国男性中最常见的癌症。前列腺癌的手术结果仍不一致。社会经济因素等障碍可能在患者拒绝推荐的癌症导向手术的决定中起作用。方法。使用内布拉斯加州癌症登记数据计算推荐进行癌症导向手术的前列腺癌患者比例和手术拒绝率。应用多变量逻辑回归分析与手术拒绝相关的社会经济指标。结果。1995年至2012年,内布拉斯加州有14,876名前列腺癌患者被推荐进行癌症导向手术,其中576人拒绝手术。18年间手术总体拒绝率为3.9%。早期前列腺癌患者更有可能拒绝手术。黑人、单身或由医疗补助/医疗保险覆盖的患者拒绝手术的几率增加。结论。社会经济因素与拒绝推荐的前列腺癌手术治疗有关。应消除此类障碍,以提高手术治疗的利用率和患者的福祉。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a3/4418003/9a87693de4b4/PC2015-829439.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a3/4418003/33dc063fe929/PC2015-829439.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a3/4418003/9a87693de4b4/PC2015-829439.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a3/4418003/33dc063fe929/PC2015-829439.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a3/4418003/9a87693de4b4/PC2015-829439.002.jpg

相似文献

1
Prostate cancer patients' refusal of cancer-directed surgery: a statewide analysis.前列腺癌患者拒绝针对癌症的手术:一项全州范围的分析。
Prostate Cancer. 2015;2015:829439. doi: 10.1155/2015/829439. Epub 2015 Apr 20.
2
Refusal of Cancer-Directed Surgery in Patients with Colon Cancer: Risk Factors of Refusal and Survival Data.拒绝接受结肠癌手术的患者:拒绝手术的风险因素和生存数据。
Ann Surg Oncol. 2021 Feb;28(2):606-616. doi: 10.1245/s10434-020-08783-1. Epub 2020 Jul 7.
3
Treatment of stage I-III rectal cancer: Who is refusing surgery?治疗 I-III 期直肠癌:谁在拒绝手术?
J Surg Oncol. 2020 May;121(6):990-1000. doi: 10.1002/jso.25873. Epub 2020 Feb 23.
4
Refusal of Cancer-Directed Surgery in Head and Neck Squamous Cell Carcinoma Patients.头颈部鳞状细胞癌患者拒绝针对癌症的手术治疗
Laryngoscope. 2019 Jun;129(6):1368-1373. doi: 10.1002/lary.27116. Epub 2018 Aug 2.
5
Sociodemographic predictors of surgery refusal in patients with stage I-III colon cancer.社会人口统计学因素预测 I-III 期结肠癌患者的手术拒绝率。
J Surg Oncol. 2020 Jun;121(8):1306-1313. doi: 10.1002/jso.25917. Epub 2020 Mar 29.
6
Survival after refusal of surgical treatment for locally advanced laryngeal cancer.拒绝手术治疗局部晚期喉癌后的生存情况。
Oral Oncol. 2017 Aug;71:34-40. doi: 10.1016/j.oraloncology.2017.05.019. Epub 2017 Jun 6.
7
Refusal of cancer-directed surgery strongly impairs survival of patients with localized hepatocellular carcinoma.拒绝针对癌症的手术会严重损害局限性肝细胞癌患者的生存率。
Int J Surg Oncol. 2010;2010:381795. doi: 10.1155/2010/381795. Epub 2010 Dec 20.
8
Factors associated with refusing surgery versus planned nonoperative management for rectal cancer.直肠癌患者拒绝手术与计划采取非手术治疗的相关因素。
Surgery. 2022 Nov;172(5):1309-1314. doi: 10.1016/j.surg.2022.05.035. Epub 2022 Aug 26.
9
Correlates of Refusal of Surgery in the Treatment of Non-metastatic Pancreatic Adenocarcinoma.非转移性胰腺导管腺癌患者拒绝手术治疗的相关因素。
Ann Surg Oncol. 2019 Jan;26(1):98-108. doi: 10.1245/s10434-018-6708-y. Epub 2018 Aug 25.
10
Refusal of curative radiation therapy and surgery among patients with cancer.癌症患者拒绝接受根治性放疗和手术。
Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):756-64. doi: 10.1016/j.ijrobp.2014.03.024. Epub 2014 May 3.

引用本文的文献

1
A population-based propensity score matching analysis of risk factors and the impact on survival associated with refusal of cancer-directed surgery in patients with prostate cancer.一项基于人群的倾向评分匹配分析,研究前列腺癌患者拒绝癌症导向手术的危险因素及其对生存的影响。
Sci Rep. 2024 Apr 25;14(1):9494. doi: 10.1038/s41598-024-60180-w.
2
Refusal of Surgery in Pituitary Adenoma Patients: A Population-Based Analysis.垂体腺瘤患者拒绝手术治疗:一项基于人群的分析。
Cancers (Basel). 2022 Oct 30;14(21):5348. doi: 10.3390/cancers14215348.
3
Factors Associated With Patient's Refusal of Recommended Cancer Surgery: Based on Surveillance, Epidemiology, and End Results.

本文引用的文献

1
Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis.临床局限性前列腺癌的主要治疗方法:全面的终生成本效益分析。
BJU Int. 2013 Mar;111(3):437-50. doi: 10.1111/j.1464-410X.2012.11597.x. Epub 2012 Dec 28.
2
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.前列腺癌筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2012 Jul 17;157(2):120-34. doi: 10.7326/0003-4819-157-2-201207170-00459.
3
Outcome analysis of breast cancer patients who declined evidence-based treatment.
与患者拒绝推荐的癌症手术相关的因素:基于监测、流行病学和最终结果。
Front Public Health. 2022 Jan 17;9:785602. doi: 10.3389/fpubh.2021.785602. eCollection 2021.
4
Age as a Barrier to Surgical Stabilization of Rib Fractures in Patients with Flail Chest.年龄对连枷胸患者肋骨骨折手术固定的阻碍。
Am Surg. 2023 Apr;89(4):927-934. doi: 10.1177/00031348211047490. Epub 2021 Nov 3.
拒绝接受基于证据的治疗的乳腺癌患者的结局分析。
World J Surg Oncol. 2012 Jun 26;10:118. doi: 10.1186/1477-7819-10-118.
4
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
5
MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer.磁共振成像和磁共振波谱成像在前列腺癌治疗前评估中的应用
Br J Radiol. 2005;78 Spec No 2:S103-11. doi: 10.1259/bjr/11253478.
6
30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.前列腺癌根治术后30天死亡率及主要并发症:年龄和合并症的影响
J Natl Cancer Inst. 2005 Oct 19;97(20):1525-32. doi: 10.1093/jnci/dji313.
7
5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study.根治性前列腺切除术后5年的泌尿及性功能结果:前列腺癌结局研究的结果
J Urol. 2005 May;173(5):1701-5. doi: 10.1097/01.ju.0000154637.38262.3a.
8
Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study.临床局限性前列腺癌初始治疗中的种族差异。前列腺癌结局研究的结果。
J Gen Intern Med. 2003 Oct;18(10):845-53. doi: 10.1046/j.1525-1497.2003.21105.x.
9
Estimating health care costs related to cancer treatment from SEER-Medicare data.利用监测、流行病学和最终结果(SEER)-医疗保险数据估算与癌症治疗相关的医疗保健成本。
Med Care. 2002 Aug;40(8 Suppl):IV-104-17. doi: 10.1097/00005650-200208001-00014.
10
Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.临床局限性前列腺癌根治性前列腺切除术后的泌尿和性功能:前列腺癌结局研究
JAMA. 2000 Jan 19;283(3):354-60. doi: 10.1001/jama.283.3.354.